Introduction
Experimental autoimmune encephalomyelitis (EAE) serves as a rodent model for multiple sclerosis (MS) and shares some aspects of this human neurodegenerative disease and T cell dependency (Sospedra and Martin, 2005; Baxter, 2007) . EAE can be actively induced upon immunization with encephalitogenic peptides (Sospedra and Martin, 2005; Baxter, 2007) or by passive transfer of myelin auto-Ag reactive T cells (Linington et al., 1993; Miller et al., 1995; Williams et al., 2011) . EAE pathology is characterized by the massive CNS infiltration of myelin-reactive CD4 + T cells (Olsson, 1995; Fife et al., 2000) , along with other inflammatory cells, such as macrophages and neutrophils (Juedes et al., 2000; Kroenke et al., 2008; Li et al., 2011) , causing CNS inflammation and variable paralysis. The major CNS-invading CD4 + T cells are T helper type 1 cells (Th1) and Th17 cells, which produce inflammatory cytokines IFN-γ and IL-17, respectively. Although IFN-γ can contribute to disease (Olsson et al., 1995; Karpus et al., 1998; Juedes et al., 2000) , Th17 cells have been found to be the major encephalitogenic T cells (Hofstetter et al., 2005; Komiyama et al., 2006; Sutton et al., 2006) , which can be induced by IL-23 (Cua et al., 2003) . In fact, IL-23p19 −/− mice have been found to be resistant to EAE (Cua et al., 2003; Langrish et al., 2005) . IL-23 exerts its role in EAE through proliferation of Th17 cells (Aggarwal et al., 2003; Langrish et al., 2005) , and adoptively transferred IL-23-driven Th17 cells have been found to be highly potent in promoting EAE (Langrish et al., 2005) . Recent findings have shown that IL-23 also stimulates GM-CSF-producing autoreactive CD4 + T cells, which in turn induce Th17 cells, causing an exacerbation of disease because of myeloid cell recruitment to the CNS (Codarri et al., 2011; El-Behi et al., 2011) . Alternatively, Th17 cells can also be induced upon concomitant stimulation by TGF-β and IL-6 (Veldhoen et al., 2006; Kimura et al., 2007; Okamoto et al., 2010) . Stimulation of anti-inflammatory Th2 cells has been shown to confer protection against EAE. This Th2 cell-dependence is demonstrated by the production of the anti-inflammatory cytokines, IL-4 (Falcone et al., 1998; Inobe et al., 1998) and IL-13 (Offner et al., 2005; Ochoa-Repáraz et al., 2008) . However, regulatory T cells are the predominant T cell subset responsible for protection via IL-10 (Faria et al., 2003; Stephens et al., 2009 ), TGF-β (Chen et al., 2003 Faria et al., 2003; Zheng et al., 2008) , and now IL-35 (Collison et al., 2010; Kochetkova et al., 2010) . These regulatory T cells can vary phenotypically (Stephens et al., 2009; Kochetkova et al., 2010; Sakaguchi et al., 2010; Campbell and Koch, 2011) , but most often the inducible regulatory CD4 + T cells express CD25 and FoxP3 (Stephens et al., 2009; Campbell and Koch, 2011) and are commonly referred to as T reg cells. While T reg cells are induced during EAE (McGeachy et al., 2005; Rynda-Apple et al., 2011) , these often lack the ability to ameliorate disease. Thus, alternative means to induce T reg cells are sought. Along these lines, Ag-specific T reg cells are preferential, and
